Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Intervir Therapeutics

Intervir Therapeutics
2013 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Developer of drugs intended to treat viral diseases. The company's drugs are discovered to treat viral diseases using structure action relationships (SAR) that inhibit virus-host interactions required for egress and spread of infectious virus from the cell, enabling doctors to treat diseases caused by filoviruses (Ebola and Marburg), arenaviruses (Lassa Fever and Junín), influenza A virus and rhabdoviruses (rabies).

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • 3160 Chestnut Street
  • Suite 200
  • Philadelphia, PA 19104
  • United States

+1 (610) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Intervir Therapeutics’s full profile, request a free trial.

Intervir Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 01-Aug-2015 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Intervir Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
UPstart Accelerator/Incubator 000 0000 000000 0

Intervir Therapeutics Executive Team (2)

Name Title Board
Seat
Contact
Info
Mike Saporito Chief Executive Officer & President

1 Former Executive

You’re viewing 1 of 2 executives. Get the full list »